Table 2.

Baseline characteristics of hormone receptor-positive patients by first-line treatment after diagnosis of metastatic breast cancer (n = 530)

Data are n (%) unless otherwise noted.

^a151 patients who were stage IV at initial diagnosis were not included; percentages are based on nonmissing data.

^bTime from the end of nonhormonal adjuvant treatment to metastatic diagnosis. Computed only for patients diagnosed in stages I-III or more than 14 days between initial and metastatic diagnosis.

Abbreviation: MBC, metastatic breast cancer.